 "Additional 5,240 vials of Amphotericin B allocated to Karnataka")
Union Minister for Chemicals and Fertilizers D V Sadananda Gowda on Wednesday said additional 5,240 vials of Liposomal Amphotericin B, which is used in the treatment of black fungus, has been allocated to Karnataka.
"In Karnataka, additional 5,240 vials of Liposomal Amphotericin B have been allocated today," Gowda said in a tweet.
The Minister, who is an MP from Bengaluru North said, a total of 60,350 vials have been allocated to the state till now ensuring its smooth supply to patients.
The government has been taking various steps to enhance the availability of Amphotericin B in the country to cater to the sudden increase in demand for the medication, including giving a boost to domestic manufacturing.
Gowda also said, additional 61,120 vials of Liposomal Amphotericin B have been allocated to all States, UTs and Central Institutions today.
So far, approximately 7.9 Lakh vials have been allocated across the country, maintaining adequate availability to patients of Mucormycosis, he noted.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app